We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.05B
AUM Growth
+$15.8M
Cap. Flow
-$99.8M
Cap. Flow %
-4.88%
Top 10 Hldgs %
44.82%
Holding
175
New
9
Increased
44
Reduced
72
Closed
13

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$16.8M
2
MSFT icon
Microsoft
MSFT
+$11.9M
3
ABBV icon
AbbVie
ABBV
+$11.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.03M
5
MCD icon
McDonald's
MCD
+$5.54M

Sector Composition

Rank Sector Weight
1 Healthcare 26.62%
2 Technology 13.9%
3 Consumer Discretionary 12.79%
4 Financials 11.16%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
151
Everpure Inc
P
$38.5B
$257K 0.01%
+9,612
New +$280K
TT icon
152
Trane Technologies
TT
$105B
$248K 0.01%
1,477
+19
+1% +$3.14K
TXG icon
153
10x Genomics
TXG
$7.35B
$245K 0.01%
+6,715
New +$220K
LQD icon
154
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$242K 0.01%
+2,291
New +$240K
ZGN icon
155
Zegna
ZGN
$3.72B
$239K 0.01%
22,800
EWJ icon
156
iShares MSCI Japan ETF
EWJ
$23.2B
$230K 0.01%
4,231
BNTX icon
157
BioNTech
BNTX
$23.2B
$226K 0.01%
+1,505
New +$232K
DVA icon
158
DaVita
DVA
$11.6B
$224K 0.01%
3,000
UBS icon
159
UBS Group
UBS
$177B
$217K 0.01%
11,666
+60
+0.5% +$1.02K
DB icon
160
Deutsche Bank
DB
$72.4B
$185K 0.01%
16,400
IOVA icon
161
Iovance Biotherapeutics
IOVA
$3.02B
$179K 0.01%
28,086
+410
+1% +$3.2K
VOD icon
162
Vodafone
VOD
$37.2B
$166K 0.01%
16,420
AKAM icon
163
Akamai
AKAM
$17.9B
-3,652
Closed -$293K
BX icon
164
Blackstone
BX
$111B
-2,698
Closed -$226K
CI icon
165
Cigna
CI
$73.8B
-1,030
Closed -$286K
GBDC icon
166
Golub Capital BDC
GBDC
$3.44B
-10,118
Closed -$125K
GH icon
167
Guardant Health
GH
$22.1B
-6,784
Closed -$365K
HEDJ icon
168
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
-32,560
Closed -$1.01M
MFIC icon
169
MidCap Financial Investment
MFIC
$806M
-13,246
Closed -$135K
NHI icon
170
National Health Investors
NHI
$3.54B
-4,000
Closed -$226K
NTLA icon
171
Intellia Therapeutics
NTLA
$1.68B
-5,039
Closed -$282K
RF icon
172
Regions Financial
RF
$27B
-10,621
Closed -$213K
SDIV icon
173
Global X SuperDividend ETF
SDIV
$1.22B
-5,800
Closed -$131K
VTRS icon
174
Viatris
VTRS
$18.6B
-24,641
Closed -$210K
ABMD
175
DELISTED
Abiomed Inc
ABMD
-1,181
Closed -$290K

Similar funds

Bank Pictet & Cie (Europe)'s Q4 2022 Portfolio in Review

As of Q4 2022, Bank Pictet & Cie (Europe) held 175 positions worth $2.05B, up 0.78% from $2.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Bank Pictet & Cie (Europe) withdrew a net $99.8M in Q4 2022, closing 13 positions and reducing 72 holdings. Its most notable exit was WisdomTree Europe Hedged Equity Fund, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bank Pictet & Cie (Europe) opened a new position in Neogen worth $1.03M.

  • Bank Pictet & Cie (Europe)'s largest Q4 2022 buy was Neogen: 67,550 shares worth $1.03M.
  • Bank Pictet & Cie (Europe) added most to Moderna in Q4 2022, an estimated $16.8M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $22.2M.
  • Bank Pictet & Cie (Europe) fully exited WisdomTree Europe Hedged Equity Fund in Q4 2022, selling an estimated $1.01M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 45% of its $2.05B portfolio in Q4 2022.
  • Bank Pictet & Cie (Europe) opened 9 new positions and closed 13 in Q4 2022.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 0.78% quarter-over-quarter to $2.05B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.